ConductScience.org, home

Paper41348017

Optimizing the right time to start sickle cell therapies.

Martin OY and 1 other. Hematology Am Soc Hematol Educ Program, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Optimizing the right time to start sickle cell therapies. Papers, record 41348017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41348017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimizing the right time to start sickle cell therapies.
PubMed
Journal
Hematology Am Soc Hematol Educ Program
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-07-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martin OYOlufunke Y
2Jacob SASeethal A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, Sickle CellMajor topic
HydroxyureaMajor topic
Genetic TherapyMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Humans
Antibodies, Monoclonal, Humanized
Glutamine
Benzaldehydes
Pyrazines
Pyrazoles

Source PubMed

Download CSV of topics

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116382063Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.N Engl J Med2005https://conductscience.org/library/papers/16382063PubMed
241573102Acute pain in pediatric patients with SCD without chronic pain is associated with elevated VCAM-1 and P-selectin adhesion.Blood Vessel Thromb Hemost2026https://conductscience.org/library/papers/41573102PubMed
341438211Hydroxyurea to decrease stroke risk in children with sickle cell anemia: a systematic review and meta-analysis.Blood Glob Hematol2025https://conductscience.org/library/papers/41438211PubMed
434850378Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.Br J Haematol2022https://conductscience.org/library/papers/34850378PubMed
527965196Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.Blood2017https://conductscience.org/library/papers/27965196PubMed
624891147Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease.Am J Hematol2014https://conductscience.org/library/papers/24891147PubMed
715596731A multimodal approach to managing the symptoms of multiple sclerosis.Neurology2004https://conductscience.org/library/papers/15596731PubMed
827858994Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.Br J Haematol2017https://conductscience.org/library/papers/27858994PubMed
934889416Indications for transfusion in the management of sickle cell disease.Hematology Am Soc Hematol Educ Program2021https://conductscience.org/library/papers/34889416PubMed
1036096996Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.Transfus Apher Sci2022https://conductscience.org/library/papers/36096996PubMed
117715639Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.N Engl J Med1995https://conductscience.org/library/papers/7715639PubMed
1229797644Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.Pediatr Blood Cancer2018https://conductscience.org/library/papers/29797644PubMed
1339644008Sickle cell disease in India: the journey and hope for the future.Hematology Am Soc Hematol Educ Program2024https://conductscience.org/library/papers/39644008PubMed
1426670617
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Lancet2016https://conductscience.org/library/papers/26670617PubMed
158555802Improved survival in homozygous sickle cell disease: lessons from a cohort study.BMJ1995https://conductscience.org/library/papers/8555802PubMed
1630403943A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.N Engl J Med2018https://conductscience.org/library/papers/30403943PubMed
1729542687Sickle cell disease.Nat Rev Dis Primers2018https://conductscience.org/library/papers/29542687PubMed
1833469520Hematopoietic Cell Transplantation for Sickle Cell Disease.Front Pediatr2020https://conductscience.org/library/papers/33469520PubMed
1933067606Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.Blood2021https://conductscience.org/library/papers/33067606PubMed
2034789492Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.BMJ Open2021https://conductscience.org/library/papers/34789492PubMed

See all 51 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41348017

GET https://conductscience.org/api/papers/v1/41348017/references?page=2